The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Tetravac, suspension for injectionDiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, adsorbed

0.5 millilitre(s) Suspension for injection

Sanofi PasteurPA2131/009/001

Main Information

Trade NameTetravac, suspension for injectionDiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, adsorbed
Active SubstancesPurified tetanus toxoid
Purified Diphtheria Toxoid Ph. Eur.
Adsorbed purified pertussis toxoid
Adsorbed purified filamentous haemagglutinin
Inactivated Poliomyelitis Virus Ph. Eur
Inactivated type 1 poliovirus
Inactivated type 2 poliovirus
Inactivated type 3 poliovirus
Strength0.5 millilitre(s)
Dosage FormSuspension for injection
Licence HolderSanofi Pasteur
Licence NumberPA2131/009/001

Group Information

ATC CodeJ07CA Bacterial and viral vaccines, combined
J07CA02 diphtheria-pertussis-poliomyelitis-tetanus

Status

Authorised/WithdrawnAuthorised
Licence Issued23/03/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back